Table 2. Survival of F98 glioma-bearing rats after carboplatin chemotherapy.
Carboplatin was delivered by CED on day 13 after tumor inoculation for groups 2, 3 and 4; and on day 8 for group 5. A survival time of 200 days was considered as the endpoint of the study. Rats still alive at 200 days after inoculation of 103 F98 glioma cells were euthanized.
| Group | N* | Carboplatin CED treatment (dose/volume) | Survival time (days)
|
% Increased life span
|
|||
|---|---|---|---|---|---|---|---|
| Range | Mean ± SE‡ | Median | Mean | Median | |||
| 1 | 7 | Untreated | 22–34 | 29 ± 2 | 30 | - | - |
| 2 | 10 | 20 μg/20 μl | 32–120 | 55 ± 8 | 45 | 90 | 63 |
| 3 | 7 | 40 μg/40 μl | 16–59 | 37 ± 6 | 32 | 26 | 7 |
| 4 | 6 | 100 μg/20 μl | 16–52 | 29 ± 5 | 26 | 0 | −13 |
| 5 | 8 | 40 μg/40 μl (at day 8) | 27–200§ | 64 ± 22 (biased) | 33 | 120 (biased) | 10 |
N is the number of animals per group.
One rat was still alive at day 200.
SE is the standard error of the mean.